Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738537 · ClinicalTrials.gov registry record
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
A clinical trial of Mitral Valve Prolapse, sponsored by Northwell Health.
- Recruiting
- Registry status
- 150
- Enrollment target
- 5
- Study locations
NCT06738537: Recruiting study of Mitral Valve Prolapse, sponsored by Northwell Health.
NCT06738537 is a study of Mitral Valve Prolapse that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 150 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06738537, a study of Mitral Valve Prolapse, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.
Primary Outcome
The investigators will conduct qualitative focus groups among patients with severe degenerative MR to elicit the range of outcomes patients consider important when selecting treatment options. These data will be analyzed to develop a consolidated framework of outcomes patients value. Using these data, the investigators will then create and administer a quantitative survey to characterize how patients with severe MR prioritize outcomes when making treatment decisions.
Conditions Studied
Interventions
- OTHER Focus Groups/Quantitative Survey for Patients
- OTHER Focus Group/Quantitative Survey for HCPs
- OTHER Qualitative Focus Group
Study Locations (5)
California
- Cedars-Sinai Medical Center - Los Angeles
Missouri
- Saint Luke's Hospital - Kansas City
New York
- Northwell Health - New York
Ohio
- Cleveland Clinic - Cleveland
West Virginia
- West Virginia University Medicine - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2025-02-28 |
What NCT06738537 shows while recruiting
NCT06738537 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Mitral Valve Prolapse appearing as the primary indexed condition, and to 3 interventions - of which Focus Groups/Quantitative Survey for Patients is the first listed.
NCT06738537 lists 5 locations in 5 states (California, Missouri, New York).
Frequently Asked Questions
What is clinical trial NCT06738537 about?
NCT06738537 is a clinical study titled "Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse". This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study ...
What is the current status of trial NCT06738537?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2023-09-01. Estimated completion is 2025-02-28.
What conditions does trial NCT06738537 study?
This clinical trial studies the following conditions: Mitral Valve Prolapse.
What interventions are being tested in trial NCT06738537?
The interventions under investigation include: Focus Groups/Quantitative Survey for Patients (OTHER), Focus Group/Quantitative Survey for HCPs (OTHER), Qualitative Focus Group (OTHER).
Who is sponsoring clinical trial NCT06738537?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06738537 being conducted?
This trial has 5 study locations across California, Missouri, New York, Ohio, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI